Latest filing published 01 Dec 2020 for RepliCel Life Sciences Inc., €1,444.
No signal scores available.
Rolf Hoffmann appears in our data through filings on RepliCel Life Sciences Inc. shares, published by SEDI. The record holds 3 filings, for trades running from 10 August 2016 to 30 November 2020.
Every open-market trade on record is a sale: 2 sales worth €3,623. In 2020 alone, the filings show no purchases and 2 sales.
The newest entry dates from 1 December 2020: an open-market sale of €1,444, in RepliCel Life Sciences Inc. The median gap between a trade and its publication by SEDI is 36 days. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations